作者: Castan Remi
DOI:
关键词: FOLFIRI 、 Folinic acid 、 Fluorouracil 、 Medicine 、 Internal medicine 、 Aflibercept 、 Colorectal cancer 、 Oncology
摘要: The present invention provides a pharmaceutical composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinocetan (FOLFIRI) useful in the treatment of Colorectal cancer (CRC).